FDA Lowers Some BsUFA II Fees for Fiscal 2019
The FDA released its BsUFA II fees for FY 2019, lowering biological product development fees from the fiscal 2018 rates while leaving application and program fees unchanged.
Source: Drug Industry Daily
The FDA released its BsUFA II fees for FY 2019, lowering biological product development fees from the fiscal 2018 rates while leaving application and program fees unchanged.
Source: Drug Industry Daily